Items where authors include "Sharrack, S."

Article

Harnden, K., Sidhu, N., Rowbotham, E. et al. (8 more authors) (2025) Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study. The Lancet Rheumatology. ISSN 2665-9913

Di Matteo, A. orcid.org/0000-0003-0867-7051, Mankia, K. orcid.org/0000-0002-7945-6582, Garcia-Montoya, L. et al. (5 more authors) (2024) Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD Open, 10 (2). e003927. ISSN 2056-5933

Conference or Workshop Item

Sharrack, S., Yu, X., Jayaraman, A. et al. (17 more authors) (2025) POS0067 Elevated serum peptidylarginine deiminase 4 (PAD4) levels in anti-CCP antibody positive at-risk individuals with arthralgia who progress to rheumatoid arthritis. In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Proceedings Paper

Sharrack, S., Samuels, T., Skarbek, S. et al. (5 more authors) (2024) P10 Haemophagocytic lymphohistiocytosis in the returning traveller with fever... especially if slow to defervesce on treatment! In: Rheumatology Advances in Practice. Case-based Conference 2024, 05-06 Nov 2024, Leeds, United Kingdom. Oxford University Press (OUP) .